GLP1R and diabetes mellitus: Even before its approval, a 2009 joint consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes recommended the use of GLP-1 receptor agonists in patients where minimizing hypoglycemia or promoting weight loss was an important consideration [33].